Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IEQFO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2023173132A1 ADC-5
|
|||||
| Synonyms |
ADC-5
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.4
|
|||||
| Structure |
|
|||||
| Antibody Name |
COMP mAb1
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
P9
|
Payload Info | ||||
| Linker Name |
DIBAC-suC-PEG12
|
Linker Info | ||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
DIBAC-suC-PEG12-P9
|
|||||